Hidden crisis: drug-resistant bacteria outbreak in COVID-19 ICUs
NCT ID NCT05055479
First seen Nov 19, 2025 · Last updated Apr 29, 2026 · Updated 20 times
Summary
This study looked at how a hospital intensive care unit (ICU) managed an outbreak of a hard-to-treat bacteria called VIM-producing Enterobacter cloacae during the COVID-19 pandemic. Researchers reviewed the care of 14 ICU patients who had this bacteria between March and October 2020. The goal was to understand what measures helped control the spread and improve patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTEROBACTERIACEAE INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens Picardie
Amiens, Picardie, 80054, France
Conditions
Explore the condition pages connected to this study.